Treatment options for PNET liver metastases: a systematic review

BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40–80% of patients with PNET are metastatic at presentation, usually involving the liver (40–93%). Liver metastasis represents the most significant prognostic factor. The aim of this study is to present an up-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nigri, Giuseppe, Petrucciani, Niccolò, Debs, Tarek, Mangogna, Livia Maria, Crovetto, Anna, Moschetta, Giovanni, Persechino, Raffaello, Aurello, Paolo, Ramacciato, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046097/
https://www.ncbi.nlm.nih.gov/pubmed/30007406
http://dx.doi.org/10.1186/s12957-018-1446-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046097/
https://www.ncbi.nlm.nih.gov/pubmed/30007406
http://dx.doi.org/10.1186/s12957-018-1446-y

Ejemplares similares